Possible role of ammonia on the deposition, retention, and absorption of nicotine in humans while smoking.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic perspective with no new empirical human data
PubMed 17316028 · doi:10.1021/tx600290v
What was done
This perspective reviewed the physical and chemical dynamics of tobacco smoke aerosol, focusing on the proposed role of ammonia in the deposition, retention, and absorption kinetics of nicotine in the human respiratory tract.
What was found
The abstract reports no numerical data. It describes three mechanisms of smoke constituent absorption: direct gas-phase deposition, particle deposition followed by biological diffusion, and particle evaporation followed by gas-phase deposition. Mainstream smoke ammonia evaporates from aerosol particles faster than nicotine, making it unlikely that ammonia substantially alters particulate nicotine volatility. Due to the high surface area and buffering capacity of the lung-blood interface, inhaled nicotine is absorbed rapidly regardless of particle acid-base status. Consequently, static measurements such as trapped freebase nicotine fractions, "smoke pH", and "pHeff" are uninformative for predicting nicotine uptake in smokers.
Why it matters
It provides a theoretical counterargument to claims that ammonia additives significantly increase nicotine bioavailability by manipulating smoke pH and freebase nicotine delivery in the lungs.
Limits
The paper is a narrative overview and theoretical synthesis rather than a primary clinical or laboratory investigation. The abstract provides no primary human pharmacokinetic measurements, sample sizes, or quantitative experimental validation.
Cited by
- contradicts Adding ammonia compounds like diammonium phosphate converts nicotine to freebase form, allowing it to cross the blood-brain barrier faster than natural nicotine salts.